Terumo Medical would like to give you a shot in the arm -- and your little dog, too. Terumo Medical Corporation (TMC) makes disposable hypodermic syringes, catheters, and blood collection and transfusion equipment, among other medical devices. TMC operates through three divisions: Terumo Interventional Systems (catheters, guidewires); Terumo Medical Products (monitors, syringes, veterinary products); and Terumo Transfusion Products (blood bags, collection equipment, transfusion sets). Along with the US, TMC has operations Brazil, Canada, and Mexico. A subsidiary of Terumo Corporation, TMC was founded in 1972.
A number of years ago TMC brought its US and Latin America sales and marketing operations in-house, severing a 15-year arrangement it had with Boston Scientific. TMC has distribution and manufacturing operations in the US and Canada, though some of its products are also manufactured at a facility in Japan belonging to its parent company.
Its products, which are sold by regional sales representatives, a network of distributors, and online, are targeted toward a range of medical professionals and settings including cardiologists, nurses and physicians, radiologists, vascular surgeons, and veterinarians in blood banks, clinics, and hospitals worldwide.
TMC expands its offerings primarily through researching and developing new products at its Tacura R&D division in California. Some of its successes include a series of products for its Glidewire Advantage guidewire and Pinnacle Destination Guiding sheaths lines. TMC also developed a complete line of coronary diagnostic catheters through its Terumo Interventional Systems business unit.
Along with R&D, TMC makes acquisitions here and there. In 2011 TMC expanded its line of minimally invasive surgery products by acquiring Onset Medical Corp., which specializes in sheath technology used in minimally invasive cardiology and urology procedures. Onset's sheaths allow doctors the surgical access they need to perform procedures such as valve repairs or implants, or kidney stone removals. The difference between these and other sheaths is that they limit the size of the access point, reducing the risk of excess trauma or other complications. Minimally invasive procedures are becoming more common as the tools to perform such operations become more available. Onset will become part of Terumo's Interventional Systems unit.
The company made a departure from its usual marketing channels such as in-house sales representatives and direct marketing, by launching websites for each of its different divisions that describe each product in-depth, offer a list of distributors, and the latest news on each product.
TMC is different from some other pharmaceutical companies in that it performs its own manufacturing, exporting, importing, marketing, research and development, distribution, and sales of its medical devices around the world. – less